Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karolina Slowicka

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cell Reports|September 22, 2021
A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolismLeen Catrysse, Bastiaan Maes, Parul Mehrotra, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cell Reports|September 22, 2021
A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolismLeen Catrysse, Bastiaan Maes, Parul Mehrotra, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Pageof 2